Affymax (NASDAQ:AFFY)

Affymax (NASDAQ:AFFY)


Share Price
0
Change
0 (0 %)
Market Cap
$0.00 m
Proactive Investors - Run By Investors For Investors

Affymax

Affymax, Inc. is a biopharmaceutical company engaged in developing drugs to improve the treatment of serious and often life-threatening conditions. Its product candidate, peginesatide, is for the treatment of anemia in chronic kidney disease patients on dialysis. Peginesatide is a synthetic peptide-based erythropoiesis stimulating agent (ESA), designed to stimulate production of red blood cells.

EPIC: AFFY
Market: NASDAQ:AFFY
Sector: Health Care, Equipment & Services
Website: www.affymax.com
col 3
col 4
col 5
col 6

Affymax Timeline

Copyright © Proactiveinvestors.com, 2019. All Rights Reserved - Proactive Investors North America Inc., Proactive Investors LLC

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use